Where people live and work influences how long and how well they live. Supporting community investments can diminish risk, improve outcomes, and reduce costs.
AMA J Ethics. 2019; 21(3):E262-268. doi:
10.1001/amajethics.2019.262.
Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.
AMA J Ethics. 2019; 21(4):E347-355. doi:
10.1001/amajethics.2019.347.
What are key factors for successful partnerships between health care organizations and communities? We discuss strategies for building trust and engaging effectively.
Correctional facilities’ physician employees are at risk for burnout, posttraumatic stress, and suicide. Prison reform should address needs of inmates and staff.
AMA J Ethics. 2019; 21(6):E540-545. doi:
10.1001/amajethics.2019.540.
Rachel Koch, MD, John G. Meara, MD, DMD, MBA, and Anji E. Wall, MD, PhD
Single-procedure interventions with minimal follow-up and clear quality-of-life gain are well suited for surgical mission trips. But not all risks and benefits are easily assessed.
AMA J Ethics. 2019; 21(9):E729-734. doi:
10.1001/amajethics.2019.729.
How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.